confirmed that when the level of IL-6 decreases by more than 50% after treatment in patients with severe pneumonia complicated with sepsis, the 28-day survival rate can reach 78.2%, while it is only 31.5% in patients with persistently elevated IL-6. This evidence concerns the gene IL6 and pneumonia.